ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

DCBD Board Approves Concepts For 43.5 Million In New Grants, $1.9 Million In Contract Supported Projects

November 13, 1981

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991

NHGRI’s ENCODE project to identify all genome parts.

October 10, 2003